nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—CYP3A7—Progesterone—uterine cancer	0.157	0.189	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.157	0.189	CbGbCtD
Alfentanil—CYP3A5—Progesterone—uterine cancer	0.118	0.142	CbGbCtD
Alfentanil—ABCB1—Progesterone—uterine cancer	0.0765	0.0924	CbGbCtD
Alfentanil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0692	0.0836	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—uterine cancer	0.0606	0.0733	CbGbCtD
Alfentanil—CYP3A5—Etoposide—uterine cancer	0.0526	0.0635	CbGbCtD
Alfentanil—CYP3A4—Progesterone—uterine cancer	0.0458	0.0554	CbGbCtD
Alfentanil—ABCB1—Etoposide—uterine cancer	0.0342	0.0414	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—uterine cancer	0.0233	0.0282	CbGbCtD
Alfentanil—CYP3A4—Etoposide—uterine cancer	0.0205	0.0248	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—uterine cancer	0.014	0.0169	CbGbCtD
Alfentanil—Myoclonus—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.0248	CcSEcCtD
Alfentanil—Laryngospasm—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.02	CcSEcCtD
Alfentanil—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.0183	CcSEcCtD
Alfentanil—Blood pressure increased—Progesterone—uterine cancer	0.00284	0.0165	CcSEcCtD
Alfentanil—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.0149	CcSEcCtD
Alfentanil—Disorientation—Progesterone—uterine cancer	0.0023	0.0134	CcSEcCtD
Alfentanil—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00221	0.0128	CcSEcCtD
Alfentanil—Visual disturbance—Progesterone—uterine cancer	0.00217	0.0126	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Progesterone—uterine cancer	0.00213	0.0123	CcSEcCtD
Alfentanil—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.0114	CcSEcCtD
Alfentanil—Laryngospasm—Etoposide—uterine cancer	0.00194	0.0113	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.0112	CcSEcCtD
Alfentanil—Apnoea—Etoposide—uterine cancer	0.00171	0.00993	CcSEcCtD
Alfentanil—Pain—Carboplatin—uterine cancer	0.00165	0.00956	CcSEcCtD
Alfentanil—Drowsiness—Progesterone—uterine cancer	0.00159	0.00921	CcSEcCtD
Alfentanil—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.0092	CcSEcCtD
Alfentanil—Body temperature increased—Carboplatin—uterine cancer	0.00152	0.00884	CcSEcCtD
Alfentanil—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00834	CcSEcCtD
Alfentanil—Connective tissue disorder—Progesterone—uterine cancer	0.0014	0.00812	CcSEcCtD
Alfentanil—Visual impairment—Progesterone—uterine cancer	0.00137	0.00796	CcSEcCtD
Alfentanil—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00787	CcSEcCtD
Alfentanil—Eye disorder—Progesterone—uterine cancer	0.00133	0.00772	CcSEcCtD
Alfentanil—Cardiac disorder—Progesterone—uterine cancer	0.00132	0.00767	CcSEcCtD
Alfentanil—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00762	CcSEcCtD
Alfentanil—Angiopathy—Progesterone—uterine cancer	0.00129	0.0075	CcSEcCtD
Alfentanil—Immune system disorder—Progesterone—uterine cancer	0.00129	0.00746	CcSEcCtD
Alfentanil—Mediastinal disorder—Progesterone—uterine cancer	0.00128	0.00745	CcSEcCtD
Alfentanil—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00736	CcSEcCtD
Alfentanil—Mental disorder—Progesterone—uterine cancer	0.00125	0.00724	CcSEcCtD
Alfentanil—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00722	CcSEcCtD
Alfentanil—Erythema—Progesterone—uterine cancer	0.00124	0.00719	CcSEcCtD
Alfentanil—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.007	CcSEcCtD
Alfentanil—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00695	CcSEcCtD
Alfentanil—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00679	CcSEcCtD
Alfentanil—Vision blurred—Progesterone—uterine cancer	0.00117	0.00678	CcSEcCtD
Alfentanil—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00676	CcSEcCtD
Alfentanil—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00675	CcSEcCtD
Alfentanil—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00672	CcSEcCtD
Alfentanil—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00656	CcSEcCtD
Alfentanil—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00652	CcSEcCtD
Alfentanil—Dermatitis atopic—Epirubicin—uterine cancer	0.0011	0.00638	CcSEcCtD
Alfentanil—Loss of consciousness—Progesterone—uterine cancer	0.00109	0.00632	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Etoposide—uterine cancer	0.00109	0.00631	CcSEcCtD
Alfentanil—Cough—Progesterone—uterine cancer	0.00108	0.00628	CcSEcCtD
Alfentanil—Convulsion—Progesterone—uterine cancer	0.00107	0.00623	CcSEcCtD
Alfentanil—Hypertension—Progesterone—uterine cancer	0.00107	0.00621	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00105	0.00608	CcSEcCtD
Alfentanil—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00599	CcSEcCtD
Alfentanil—Confusional state—Progesterone—uterine cancer	0.00102	0.00592	CcSEcCtD
Alfentanil—Dermatitis atopic—Doxorubicin—uterine cancer	0.00102	0.0059	CcSEcCtD
Alfentanil—Anaphylactic shock—Progesterone—uterine cancer	0.00101	0.00587	CcSEcCtD
Alfentanil—Cardiac arrest—Etoposide—uterine cancer	0.001	0.00581	CcSEcCtD
Alfentanil—Injection site pain—Epirubicin—uterine cancer	0.000997	0.00578	CcSEcCtD
Alfentanil—Nervous system disorder—Progesterone—uterine cancer	0.000993	0.00576	CcSEcCtD
Alfentanil—Tachycardia—Progesterone—uterine cancer	0.000988	0.00573	CcSEcCtD
Alfentanil—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000988	0.00573	CcSEcCtD
Alfentanil—Skin disorder—Progesterone—uterine cancer	0.000983	0.0057	CcSEcCtD
Alfentanil—Hyperhidrosis—Progesterone—uterine cancer	0.000979	0.00568	CcSEcCtD
Alfentanil—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000974	0.00565	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00095	0.00551	CcSEcCtD
Alfentanil—Hypotension—Progesterone—uterine cancer	0.000946	0.00549	CcSEcCtD
Alfentanil—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00536	CcSEcCtD
Alfentanil—Injection site pain—Doxorubicin—uterine cancer	0.000922	0.00535	CcSEcCtD
Alfentanil—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00532	CcSEcCtD
Alfentanil—Chills—Dactinomycin—uterine cancer	0.000904	0.00524	CcSEcCtD
Alfentanil—Somnolence—Progesterone—uterine cancer	0.0009	0.00522	CcSEcCtD
Alfentanil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0009	0.00522	CcSEcCtD
Alfentanil—Bronchospasm—Etoposide—uterine cancer	0.000896	0.00519	CcSEcCtD
Alfentanil—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00519	CcSEcCtD
Alfentanil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00517	CcSEcCtD
Alfentanil—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000887	0.00514	CcSEcCtD
Alfentanil—Erythema—Dactinomycin—uterine cancer	0.000877	0.00508	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Progesterone—uterine cancer	0.000874	0.00507	CcSEcCtD
Alfentanil—Fatigue—Progesterone—uterine cancer	0.000873	0.00506	CcSEcCtD
Alfentanil—Dyskinesia—Epirubicin—uterine cancer	0.000866	0.00502	CcSEcCtD
Alfentanil—Pain—Progesterone—uterine cancer	0.000866	0.00502	CcSEcCtD
Alfentanil—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.00497	CcSEcCtD
Alfentanil—Feeling abnormal—Progesterone—uterine cancer	0.000834	0.00484	CcSEcCtD
Alfentanil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000816	0.00473	CcSEcCtD
Alfentanil—Hiccups—Epirubicin—uterine cancer	0.000814	0.00472	CcSEcCtD
Alfentanil—Urticaria—Progesterone—uterine cancer	0.000804	0.00466	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—uterine cancer	0.000801	0.00465	CcSEcCtD
Alfentanil—Body temperature increased—Progesterone—uterine cancer	0.0008	0.00464	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000792	0.00459	CcSEcCtD
Alfentanil—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00459	CcSEcCtD
Alfentanil—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000756	0.00438	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—uterine cancer	0.000753	0.00437	CcSEcCtD
Alfentanil—Hypersensitivity—Progesterone—uterine cancer	0.000746	0.00433	CcSEcCtD
Alfentanil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000729	0.00423	CcSEcCtD
Alfentanil—Asthenia—Progesterone—uterine cancer	0.000726	0.00421	CcSEcCtD
Alfentanil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000725	0.00421	CcSEcCtD
Alfentanil—Pruritus—Progesterone—uterine cancer	0.000716	0.00415	CcSEcCtD
Alfentanil—Eye disorder—Etoposide—uterine cancer	0.000681	0.00395	CcSEcCtD
Alfentanil—Cardiac disorder—Etoposide—uterine cancer	0.000677	0.00392	CcSEcCtD
Alfentanil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000676	0.00392	CcSEcCtD
Alfentanil—Dizziness—Progesterone—uterine cancer	0.00067	0.00388	CcSEcCtD
Alfentanil—Angiopathy—Etoposide—uterine cancer	0.000661	0.00384	CcSEcCtD
Alfentanil—Immune system disorder—Etoposide—uterine cancer	0.000658	0.00382	CcSEcCtD
Alfentanil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00382	CcSEcCtD
Alfentanil—Mediastinal disorder—Etoposide—uterine cancer	0.000657	0.00381	CcSEcCtD
Alfentanil—Chills—Etoposide—uterine cancer	0.000654	0.00379	CcSEcCtD
Alfentanil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.00376	CcSEcCtD
Alfentanil—Vomiting—Progesterone—uterine cancer	0.000644	0.00373	CcSEcCtD
Alfentanil—Rash—Progesterone—uterine cancer	0.000638	0.0037	CcSEcCtD
Alfentanil—Dermatitis—Progesterone—uterine cancer	0.000638	0.0037	CcSEcCtD
Alfentanil—Headache—Progesterone—uterine cancer	0.000634	0.00368	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—uterine cancer	0.000617	0.00358	CcSEcCtD
Alfentanil—Pain—Dactinomycin—uterine cancer	0.000612	0.00355	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00061	0.00354	CcSEcCtD
Alfentanil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00352	CcSEcCtD
Alfentanil—Nausea—Progesterone—uterine cancer	0.000601	0.00349	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—uterine cancer	0.00059	0.00342	CcSEcCtD
Alfentanil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00338	CcSEcCtD
Alfentanil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00335	CcSEcCtD
Alfentanil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00335	CcSEcCtD
Alfentanil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00333	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—uterine cancer	0.000566	0.00328	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000565	0.00327	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—uterine cancer	0.000562	0.00326	CcSEcCtD
Alfentanil—Loss of consciousness—Etoposide—uterine cancer	0.000558	0.00323	CcSEcCtD
Alfentanil—Cough—Etoposide—uterine cancer	0.000554	0.00321	CcSEcCtD
Alfentanil—Convulsion—Etoposide—uterine cancer	0.00055	0.00319	CcSEcCtD
Alfentanil—Hypertension—Etoposide—uterine cancer	0.000548	0.00318	CcSEcCtD
Alfentanil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000545	0.00316	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000537	0.00311	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—uterine cancer	0.000527	0.00306	CcSEcCtD
Alfentanil—Confusional state—Etoposide—uterine cancer	0.000522	0.00303	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—uterine cancer	0.00052	0.00301	CcSEcCtD
Alfentanil—Anaphylactic shock—Etoposide—uterine cancer	0.000518	0.003	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—uterine cancer	0.000513	0.00298	CcSEcCtD
Alfentanil—Tachycardia—Etoposide—uterine cancer	0.000505	0.00293	CcSEcCtD
Alfentanil—Skin disorder—Etoposide—uterine cancer	0.000503	0.00292	CcSEcCtD
Alfentanil—Hyperhidrosis—Etoposide—uterine cancer	0.000501	0.0029	CcSEcCtD
Alfentanil—Hypotension—Etoposide—uterine cancer	0.000484	0.00281	CcSEcCtD
Alfentanil—Somnolence—Etoposide—uterine cancer	0.00046	0.00267	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—uterine cancer	0.000455	0.00264	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—uterine cancer	0.000455	0.00264	CcSEcCtD
Alfentanil—Rash—Dactinomycin—uterine cancer	0.000451	0.00262	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000447	0.00259	CcSEcCtD
Alfentanil—Fatigue—Etoposide—uterine cancer	0.000447	0.00259	CcSEcCtD
Alfentanil—Pain—Etoposide—uterine cancer	0.000443	0.00257	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—uterine cancer	0.000429	0.00249	CcSEcCtD
Alfentanil—Feeling abnormal—Etoposide—uterine cancer	0.000427	0.00247	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—uterine cancer	0.000425	0.00246	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—uterine cancer	0.000421	0.00244	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—uterine cancer	0.000416	0.00241	CcSEcCtD
Alfentanil—Urticaria—Etoposide—uterine cancer	0.000411	0.00239	CcSEcCtD
Alfentanil—Body temperature increased—Etoposide—uterine cancer	0.000409	0.00237	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—uterine cancer	0.000402	0.00233	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—uterine cancer	0.000397	0.0023	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—uterine cancer	0.000394	0.00228	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—uterine cancer	0.000385	0.00223	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—uterine cancer	0.000382	0.00221	CcSEcCtD
Alfentanil—Hypersensitivity—Etoposide—uterine cancer	0.000382	0.00221	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—uterine cancer	0.000379	0.0022	CcSEcCtD
Alfentanil—Asthenia—Etoposide—uterine cancer	0.000372	0.00215	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—uterine cancer	0.000372	0.00215	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—uterine cancer	0.000371	0.00215	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—uterine cancer	0.000369	0.00214	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—uterine cancer	0.000368	0.00214	CcSEcCtD
Alfentanil—Chills—Epirubicin—uterine cancer	0.000367	0.00213	CcSEcCtD
Alfentanil—Pruritus—Etoposide—uterine cancer	0.000366	0.00212	CcSEcCtD
Alfentanil—Arrhythmia—Epirubicin—uterine cancer	0.000365	0.00212	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—uterine cancer	0.000364	0.00211	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—uterine cancer	0.000358	0.00208	CcSEcCtD
Alfentanil—Erythema—Epirubicin—uterine cancer	0.000356	0.00206	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—uterine cancer	0.000353	0.00205	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—uterine cancer	0.000351	0.00203	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—uterine cancer	0.000343	0.00199	CcSEcCtD
Alfentanil—Dizziness—Etoposide—uterine cancer	0.000342	0.00199	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—uterine cancer	0.000342	0.00198	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—uterine cancer	0.000341	0.00198	CcSEcCtD
Alfentanil—Chills—Doxorubicin—uterine cancer	0.000339	0.00197	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—uterine cancer	0.000338	0.00196	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—uterine cancer	0.000335	0.00194	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—uterine cancer	0.000331	0.00192	CcSEcCtD
Alfentanil—Vomiting—Etoposide—uterine cancer	0.000329	0.00191	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—uterine cancer	0.000329	0.00191	CcSEcCtD
Alfentanil—Agitation—Epirubicin—uterine cancer	0.000327	0.0019	CcSEcCtD
Alfentanil—Rash—Etoposide—uterine cancer	0.000327	0.00189	CcSEcCtD
Alfentanil—Dermatitis—Etoposide—uterine cancer	0.000326	0.00189	CcSEcCtD
Alfentanil—Headache—Etoposide—uterine cancer	0.000324	0.00188	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—uterine cancer	0.000313	0.00181	CcSEcCtD
Alfentanil—Cough—Epirubicin—uterine cancer	0.00031	0.0018	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—uterine cancer	0.00031	0.0018	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—uterine cancer	0.000308	0.00179	CcSEcCtD
Alfentanil—Nausea—Etoposide—uterine cancer	0.000308	0.00178	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—uterine cancer	0.000307	0.00178	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—uterine cancer	0.000302	0.00175	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000301	0.00174	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—uterine cancer	0.000293	0.0017	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—uterine cancer	0.00029	0.00168	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—uterine cancer	0.000289	0.00168	CcSEcCtD
Alfentanil—Cough—Doxorubicin—uterine cancer	0.000287	0.00167	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—uterine cancer	0.000285	0.00165	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—uterine cancer	0.000285	0.00165	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—uterine cancer	0.000284	0.00165	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—uterine cancer	0.000283	0.00164	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—uterine cancer	0.000282	0.00164	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—uterine cancer	0.000281	0.00163	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000278	0.00161	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—uterine cancer	0.000271	0.00157	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—uterine cancer	0.000271	0.00157	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—uterine cancer	0.000269	0.00156	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—uterine cancer	0.000263	0.00153	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—uterine cancer	0.000262	0.00152	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—uterine cancer	0.000261	0.00151	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—uterine cancer	0.00026	0.00151	CcSEcCtD
Alfentanil—Somnolence—Epirubicin—uterine cancer	0.000258	0.0015	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—uterine cancer	0.000251	0.00146	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000251	0.00145	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—uterine cancer	0.00025	0.00145	CcSEcCtD
Alfentanil—Pain—Epirubicin—uterine cancer	0.000248	0.00144	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—uterine cancer	0.000239	0.00139	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—uterine cancer	0.000239	0.00138	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000232	0.00134	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—uterine cancer	0.000232	0.00134	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—uterine cancer	0.000231	0.00134	CcSEcCtD
Alfentanil—Pain—Doxorubicin—uterine cancer	0.00023	0.00133	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—uterine cancer	0.00023	0.00133	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—uterine cancer	0.000221	0.00128	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—uterine cancer	0.000214	0.00124	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—uterine cancer	0.000213	0.00124	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—uterine cancer	0.000212	0.00123	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—uterine cancer	0.000208	0.00121	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—uterine cancer	0.000205	0.00119	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—uterine cancer	0.000198	0.00115	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—uterine cancer	0.000193	0.00112	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—uterine cancer	0.000192	0.00111	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—uterine cancer	0.00019	0.0011	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—uterine cancer	0.000185	0.00107	CcSEcCtD
Alfentanil—Rash—Epirubicin—uterine cancer	0.000183	0.00106	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—uterine cancer	0.000183	0.00106	CcSEcCtD
Alfentanil—Headache—Epirubicin—uterine cancer	0.000182	0.00105	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—uterine cancer	0.000178	0.00103	CcSEcCtD
Alfentanil—Nausea—Epirubicin—uterine cancer	0.000172	0.001	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—uterine cancer	0.000171	0.00099	CcSEcCtD
Alfentanil—Rash—Doxorubicin—uterine cancer	0.000169	0.000982	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—uterine cancer	0.000169	0.000981	CcSEcCtD
Alfentanil—Headache—Doxorubicin—uterine cancer	0.000168	0.000976	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—uterine cancer	0.00016	0.000925	CcSEcCtD
